We are live on
!
Find out more
KA
KLCM Advisors Portfolio holdings
AUM
$1.19B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+34.45%
3 Year Est. Return
+97.42%
5 Year Est. Return
+107.96%
10 Year Est. Return
+263.06%
AUM
$843M
AUM Growth
+$33.1M
(+4.1%)
Cap. Flow
+$979K
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
50.61%
Holding
177
New
16
Increased
74
Reduced
47
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Truist Financial
TFC
|
+$14.9M |
| 2 |
Builders FirstSource
BLDR
|
+$10.4M |
| 3 |
APA Corp
APA
|
+$8.75M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$6.28M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$4.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$17.2M |
| 2 |
Newmont
NEM
|
+$8.76M |
| 3 |
Bank of America
BAC
|
+$8.22M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$7.29M |
| 5 |
Medtronic
MDT
|
+$6.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.15% |
| 2 | Industrials | 13.04% |
| 3 | Financials | 11.9% |
| 4 | Healthcare | 10% |
| 5 | Communication Services | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
3M
MMM
$90.9B
| $208K | 0.02% |
+1,520
| New | +$186K |
|
152
Toll Brothers
TOL
$13.6B
| $205K | 0.02% |
+1,326
| New | +$180K |
|
153
Hershey
HSY
$35.2B
| $205K | 0.02% |
+1,067
| New | +$207K |
|
154
Jabil
JBL
$33B
| $204K | 0.02% |
+1,705
| New | +$185K |
|
155
CVS Health
CVS
$133B
| $202K | 0.02% |
3,215
-400
| -11% | -$23.3K |
|
156
O-I Glass
OI
$1.1B
| $173K | 0.02% |
13,200
-3,000
| -19% | -$35.9K |
|
|
OSG
157
Octave Specialty Group
OSG
$243M
| $157K | 0.02% |
14,000
| – | – |
|
|
WBA
158
DELISTED
Walgreens Boots Alliance
WBA
| $120K | 0.01% |
13,399
-708,489
| -98% | -$7.29M |
|
159
SoFi Technologies
SOFI
$21B
| $86.5K | 0.01% |
11,000
| – | – |
|
160
Vuzix
VUZI
$194M
| $24.6K | ﹤0.01% |
21,000
| – | – |
|
161
Opko Health
OPK
$985M
| $14.9K | ﹤0.01% |
10,000
| – | – |
|
|
NWBO
162
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $3.2K | ﹤0.01% |
10,000
| – | – |
|
163
Gilead Sciences
GILD
$162B
| – | – |
-36,203
| Closed | -$2.48M |
|
164
Nicolet Bankshares
NIC
$3.6B
| – | – |
-3,088
| Closed | -$256K |
|
|
NNDM
165
Nano Dimension
NNDM
$316M
| – | – |
-10,000
| Closed | -$22K |
|
166
Nokia
NOK
$51B
| – | – |
-11,726
| Closed | -$44.3K |
|
167
Simon Property Group
SPG
$74.4B
| – | – |
-1,644
| Closed | -$250K |
|
|
TELL
168
DELISTED
Tellurian Inc.
TELL
| – | – |
-23,000
| Closed | -$15.9K |
|
|
SRNE
169
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| – | – |
-30,000
| Closed | -$285 |
|
Similar funds
PAMJ
CCS
CTC
NCMU
EC
MMFA
OGC
SCM
KLCM Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, KLCM Advisors held 177 positions worth $843M, up 4.1% from $809M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
KLCM Advisors's Q3 2024 filing shows 16 new, 74 increased, 47 reduced and 7 closed positions. Its largest new stake was Truist Financial: 353,576 shares worth $15.1M. The largest sale was ExxonMobil, an estimated $17.2M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Industrials and Financials.
- KLCM Advisors's largest Q3 2024 buy was Truist Financial: 353,576 shares worth $15.1M.
- KLCM Advisors added most to APA Corp in Q3 2024, an estimated $8.75M increase.
- KLCM Advisors's biggest Q3 2024 reduction was ExxonMobil, cutting an estimated $17.2M.
- KLCM Advisors fully exited Gilead Sciences in Q3 2024, selling an estimated $2.48M.
- KLCM Advisors's ten largest holdings make up 51% of its $843M portfolio in Q3 2024.
- KLCM Advisors opened 16 new positions and closed 7 in Q3 2024.
- KLCM Advisors's portfolio value rose 4.1% quarter-over-quarter to $843M.
Based on KLCM Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.